2023 Novo Holdings Bioindustrial Investments Team Annual Review/Business Update
- Established the Novo Holdings Bioindustrial Investments team, now overseeing a dynamic portfolio of 23 companies.
- Made substantial investments, solidifying Novo Holdings’ position as one of the world’s foremost active investors in the bioindustrial sector.
- Welcomed three innovative companies to our portfolio.
- Achieved significant milestones with existing portfolio companies, showcasing strong progress and commitment to sustainable solutions.
Copenhagen, Denmark, 15 March 2024 – Novo Holdings Bioindustrial Investments team today publishes its review of 2023 – paving the way for a more sustainable future.
Novo Holdings Bioindustrial Investments team understands that radical innovation is needed if we are to win the battle against global warming and its damaging effects on the health of people and the planet. Recent innovations in biological sciences and technology hold the promise to deliver the breakthroughs needed, but too few of them have been successfully commercialised to a level where they can make a meaningful, sustainable impact. The Bioindustrial Investments team remains steadfast on harnessing the power of biotechnology to deliver impactful solutions for both industry and agriculture.
